In accordance with previously published studies (37–39), the level of CD8+ cell and CD20+ B/plasma cell infiltration in both stromal and tumor areas was significantly increased in tumors previously treated with NACT (Figure 5D). The gene discussed is CD8A; the disease is neoplasm.